Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
77 hedge funds and large institutions have $50.3M invested in Applied Genetic Technologies Corporation in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 27 reducing their positions, and 26 closing their positions.
87% more call options, than puts
Call options by funds: $168K | Put options by funds: $90K
11% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 27
13% less funds holding
Funds holding: 89 → 77 (-12)
33% less capital invested
Capital invested by funds: $75.1M → $50.3M (-$24.8M)
42% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 26
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.41M |
| 2 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
+$1.05M |
| 3 |
Renaissance Technologies
New York
|
+$849K |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$836K |
| 5 |
Goldman Sachs
New York
|
+$738K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.06M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.89M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.43M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.27M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.11M |
AGTC Hedge Fund Activity: Q2 2017 in Review
77 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2017, worth a combined $50.3M — down 33% from $75.1M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of AGTC and 15 opened new positions — a net loss of 11 holders — while 27 trimmed existing stakes and 24 added.
The largest buyer was Millennium Management, adding an estimated $1.41M. The largest seller was BlackRock, cutting an estimated $3.06M.
- 77 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2017, down from 89 in Q1 2017.
- Funds reported $50.3M of Applied Genetic Technologies Corporation stock for Q2 2017, down 33% quarter-over-quarter.
- 15 funds opened new Applied Genetic Technologies Corporation positions in Q2 2017 and 26 closed out, a net change of -11 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q2 2017 was Millennium Management, an estimated $1.41M added.
- The largest Applied Genetic Technologies Corporation seller in Q2 2017 was BlackRock, an estimated $3.06M sold.
Based on aggregated 13F filings for Q2 2017.